Israel Quoted on Legal Implications of Recent NFL Protests
September 25, 2017
National Law Journal
Partner Jon Israel was quoted in a National Law Journal article, “Trump Wants NFL Players Fired. It’s Not That Simple,” covering the potential legal implications of the National Football League players’ silent protests over police violence against African American people.
Israel explained that the First Amendment and discrimination arguments won’t necessarily protect the NFL players and that there are still aspects of their agreements that could potentially allow them to be terminated.
However, Israel also discussed how unlikely it is for the NFL and its teams to take the time to terminate players in this case. “Terminating a contract in a professional sports setting is a difficult thing,” he said. “I would say, certainly, there are legal mechanisms where they could. The practical reality of the league seems that they would not do that.”
Israel explained that the First Amendment and discrimination arguments won’t necessarily protect the NFL players and that there are still aspects of their agreements that could potentially allow them to be terminated.
However, Israel also discussed how unlikely it is for the NFL and its teams to take the time to terminate players in this case. “Terminating a contract in a professional sports setting is a difficult thing,” he said. “I would say, certainly, there are legal mechanisms where they could. The practical reality of the league seems that they would not do that.”
People
Related News
July 21, 2025
In the News
Nicholas O'Keefe Assesses 'Golden Share' in US Steel Deal
Foley & Lardner LLP partner Nicholas O'Keefe commented on the 'golden share' arrangement included as part of the approval of Nippon Steel's acquisition of U.S. Steel in Agenda, a Financial Times publication.
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."